Retraction

Clazosentan, a novel endothelin A antagonist, improves cerebral blood flow and behavior after traumatic brain injury

Retraction Details

Nature of Retraction:

Retraction

Additional Notes:

William Armstead has ORI finding of misconduct; see https://ori.hhs.gov/content/case-summary-armstead-william-m

Citations (10)

10
Total Citations
1
Post-Retraction
(10.0%)
6
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
1 After 2+ years
2107 Days since retraction (latest)
Paper citing Clazosentan, a novel endothelin A antagonist, impr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Calponin and caldesmon cellular domains in reactin...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Clazosentan, a novel endothelin A antagonist, impr...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Clazosentan, a novel endothelin A antagonist, impr...
Unknown Authors
Unknown Journal
Published: Dec 2022
2107 days after retraction
Paper citing Clazosentan, a novel endothelin A antagonist, impr...
Unknown Authors
Unknown Journal
Published: Sep 2016
175 days before retraction
Paper citing Clazosentan, a novel endothelin A antagonist, impr...
Unknown Authors
Unknown Journal
Published: Aug 2016
206 days before retraction
Paper citing Clazosentan, a novel endothelin A antagonist, impr...
Unknown Authors
Unknown Journal
Published: Jun 2016
241 days before retraction
Paper citing Clazosentan, a novel endothelin A antagonist, impr...
Unknown Authors
Unknown Journal
Published: Sep 2015
522 days before retraction
Paper citing Clazosentan, a novel endothelin A antagonist, impr...
Unknown Authors
Unknown Journal
Published: Jan 2012
1869 days before retraction
Current World Literature
Unknown Authors
Current Opinion in Nephrology & Hypertension
Published: Dec 2011
1906 days before retraction
Quick Stats
Total Citations: 10
Years Since Retraction: 8.7 years
Open Access: Yes
Last Checked: Never
Related Papers